Endra Life Sciences

(NASDAQ) NDRA

Current Price$4.79

Market Cap$6.14M

Since IPO (2017)-100%

5 Year-100%

1 Year-31%

1 Month+6%

Endra Life Sciences Financials at a Glance

Market Cap

$6.14M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.03M

EPS (TTM)

$-8.91

P/E Ratio

-0.56

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$4.79

Volume

10,638

Open

$4.99

Price

$4.79

Volume

10,638

Open

$4.99

Previous Close

$4.95

Daily Range

$4.85 - $5.39

52-Week Range

$2.90 - $11.96

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$4.79

Volume

10,638

Open

$4.99

Previous Close

$4.95

Daily Range

$4.85 - $5.39

52-Week Range

$2.90 - $11.96

NDRA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Endra Life Sciences

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Alexander Y. Tokman

Website

www.endrainc.com

Headquarters

Ann Arbor, MI 48105-1570, US

NDRA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-292%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-1.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.14M

Shares Outstanding

1.24M

Volume

10.64K

Avg. Volume

108.50K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.76M

EBITDA

$5.61M

Operating Cash Flow

$5.18M

Capital Expenditure

$17.28K

Free Cash Flow

$5.20M

Cash & ST Invst.

$762.37K

Total Debt

$492.35K

Endra Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$39.53K

+14.7%

Gross Margin

0.00%

N/A

Market Cap

$6.14M

N/A

Market Cap/Employee

$292.46K

N/A

Employees

N/A

Net Income

$3.17M

+23.6%

EBITDA

$1.58M

+61.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$270.01K

-89.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$362.97K

-25.5%

Short Term Debt

$129.38K

+33.5%

Return on Assets

-1.82%

N/A

Return on Invested Capital

-1.86%

N/A

Free Cash Flow

$4.61M

-204.3%

Operating Cash Flow

$1.61M

-6.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HSCSHeartSciences Inc.

HSCSHeartSciences Inc.$1.99+2.05%

BBLGBone Biologics Corporation

BBLGBone Biologics Corporation$1.31+1.81%

BGMSBio Green Med Solution, Inc.

BGMSBio Green Med Solution, Inc.$0.98+0.66%

NAOVNanoVibronix, Inc.

NAOVNanoVibronix, Inc.$1.90+1.06%

MOVECorvex, Inc.

MOVECorvex, Inc.$14.71-7.48%

ISPCiSpecimen Inc.

ISPCiSpecimen Inc.$5.62+7.46%

BNBXBNB Plus Corp.

BNBXBNB Plus Corp.$0.50-6.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About NDRA

What is the current price of Endra Life Sciences?

Endra Life Sciences is trading at $4.95 per share.

What is the 52-week range for Endra Life Sciences?

Over the past 52 weeks, Endra Life Sciences has traded between $2.90 and $11.96.

How much debt does Endra Life Sciences have?

As of the most recent reporting period, Endra Life Sciences reported total debt of $492,352.

How much cash does Endra Life Sciences have on hand?

Endra Life Sciences reported $762,365 in cash and cash equivalents in its most recent financial results.

What is Endra Life Sciences’s dividend yield?

Endra Life Sciences does not currently have a dividend yield.

Endra Life Sciences

Endra Life Sciences Financials at a Glance

NDRA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Endra Life Sciences

NDRA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Endra Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NDRA

What is the current price of Endra Life Sciences?

What is the 52-week range for Endra Life Sciences?

How much debt does Endra Life Sciences have?

How much cash does Endra Life Sciences have on hand?

What is Endra Life Sciences’s dividend yield?

Premium Investing Services